Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending August 6, 2017

Outcomes in Patients with MYC-Positive DLBCL, Cancer; ePub 2017 Jul 27; Epperla, Maddocks, et al

More must reads

Must reads for theWeek ending July 30, 2017

How Comorbidities Impact DLBCL Outcomes in Elderly, Am J Hematol; ePub 2017 Jul 19; Saygin, et al

Survival in Patients with Plasma Cell Myeloma, Leuk Lymphoma; ePub 2017 Jul 21; Santiago, et al

More must reads

Must reads for theWeek ending July 23, 2017

Grade 3 Follicular Lymphoma Outcomes Evaluated, Clin Lymphoma Myeloma Leuk; ePub 2017 Jul 13; Ali, et al

More must reads

Must reads for theWeek ending July 2, 2017

Risk of Second Primary Malignancies in Patients with FL, Clin Lymphoma Myeloma Leuk; ePub 2017 Jun 24; Giri, et al

Detecting Bone Marrow Involvement in DLBCL, Clin Lymphoma Myeloma Leuk; ePub 2017 Jun 16; Vishnu, et al

New Treatment Approved for FL, DLBCL, and CLL, FDA news release; 2017 Jun 22

More must reads

Must reads for theWeek ending June 25, 2017

Rituximab + Chemo for Grade 3 Follicular Lymphoma, Clin Lymphoma Myeloma Leuk; ePub 2017 Jun 16; Yuan, et al

New Model Better Predicts Mortality in HIV-Related DLBCL, Leuk Lymphoma; ePub 2017 Jun 13; Chao, et al

More must reads

Pages